| Automated
Robotic Molecular Profiling in Cells for New Therapeutic Directions |
 |
Jeremy S.
Caldwell, Ph.D., Director of Molecular and Cell Biology, Genomics
Institute of the
Novartis Research Foundation |
|
Is
Repositioning a Viable Option
for Creating Differentiated Medicines? |
 |
Lee E.
Babiss, Ph.D., Vice President,
Preclinical
R&D, F. Hoffmann-La Roche Inc. |
|
